| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79362493392629399a529d819cdccd8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2015-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c769d090be85028b287e94f0326dfd4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bdd622ffbc933ea421a8a9f91d26d38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88afd42b863b1172619921730c8bce34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78d13db53d1438f6ae0d4ef50a7be569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dd4761c5cf42f5c878a4a63b90b5510 |
| publicationDate |
2021-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MA-40480-B1 |
| titleOfInvention |
Process for the crystallization of aripiprazole derivatives in sustained-release formulations for the treatment of schizophrenia |
| abstract |
The present invention relates to methods of producing a depot injection of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have an area of from about 0.50 to about 3.3 m² / g; and aripiprazole lauroxil crystals produced by such methods. The present invention relates to a process for the manufacture of a compound of formula (a) in crystalline form wherein ra is ch20c (o) r and wherein r1 is a substituted or unsubstituted aliphatic moiety. |
| priorityDate |
2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |